A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
This study has been completed.
Sponsor:
Hoffmann-La Roche
Information provided by (Responsible Party):
Hoffmann-La Roche
ClinicalTrials.gov Identifier:
NCT01018173
First received: November 20, 2009
Last updated: March 2, 2015
Last verified: March 2015
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
This randomized, double-blind, placebo-controlled parallel arm study will assess efficacy and safety and the effects of taspoglutide on cardiovascular events in patients with inadequately controlled type 2 diabetes mellitus and established cardiovascular disease. Patients will be randomized to receive either taspoglutide subcutaneously (sc) 10mg weekly for 4 weeks followed by 20mg sc weekly, or weekly sc placebo, in addition to background anti-hyperglycemic medication and standard of care treatment for cardiovascular disease. Anticipated time on study treatment is up to 2 years. Target sample size is 2000 patients.
| Condition | Intervention | Phase |
|---|---|---|
|
Diabetes Mellitus, Type 2 |
Drug: placebo Drug: taspoglutide |
Phase 3 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Double Blind (Subject, Investigator) Primary Purpose: Treatment |
| Official Title: | A Randomized Double Blind, Placebo-controlled Clinical Trial to Assess the Effects of Taspoglutide (RO5073031) on Cardiovascular Outcomes in Subjects With Inadequately Controlled Type 2 Diabetes and Established Cardiovascular Disease |
Resource links provided by NLM:
Further study details as provided by Hoffmann-La Roche:
Primary Outcome Measures:
- Time to cardiovascular composite primary endpoints [ Time Frame: event-driven, cardiovascular assessments weeks 1,4,12 and every 3 to 4 months thereafter ] [ Designated as safety issue: No ]
Secondary Outcome Measures:
- Secondary cardiovascular composite endpoints [ Time Frame: event-driven, cardiovascular assessments weeks 1,4,12 and every 3 to 4 months thereafter ] [ Designated as safety issue: No ]
- Individual components of primary cardiovascular composite endpoints [ Time Frame: event-driven, cardiovascular assessments weeks 1,4,12 and every 3 to 4 months thereafter ] [ Designated as safety issue: No ]
- Total mortality [ Time Frame: assessed at end of study, week 104 ] [ Designated as safety issue: No ]
- Metabolic and renal function parameters: HbA1c, fasting plasma glucose, body weight, lipid profile, ACR, albuminuria, GFR [ Time Frame: laboratory assessments weeks 4 and 12, and every 3 to 6 months thereafter ] [ Designated as safety issue: No ]
| Enrollment: | 2118 |
| Study Start Date: | January 2010 |
| Study Completion Date: | January 2011 |
| Primary Completion Date: | January 2011 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
| Experimental: 1 |
Drug: taspoglutide
10 mg sc weekly for 4 weeks, followed by 20 mg sc weekly
|
| Placebo Comparator: 2 |
Drug: placebo
sc weekly
|
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- adult patients, >18 years of age
- diabetes mellitus type 2
- HbA1c >/=6.5% and </=10% at screening
- BMI >/=23kg/m2
- cardiovascular disease with onset >/=1 month prior to screening
Exclusion Criteria:
- diagnosis or history of type 1 diabetes or secondary forms of diabetes
- acute metabolic diabetic complications within past 6 months
- severe hypoglycemia </=1 month prior to screening
- clinically significant gastrointestinal disease
- history of chronic or acute pancreatitis
- current NYHA class IV heart failure or post-transplantation cardiomyopathy
- severely impaired renal function
Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01018173
Hide Study Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01018173
Hide Study Locations
Locations
| United States, Arizona | |
| Phoenix, Arizona, United States, 85050 | |
| Tucson, Arizona, United States, 85741 | |
| United States, California | |
| Buena Park, California, United States, 90620 | |
| Calabasas, California, United States, 91302 | |
| Fresno, California, United States, 93720 | |
| Santa Ana, California, United States, 92705 | |
| Walnut Creek, California, United States, 94598 | |
| United States, Colorado | |
| Centennial, Colorado, United States, 80112 | |
| Colorado Springs, Colorado, United States, 80907 | |
| United States, Connecticut | |
| Trumbull, Connecticut, United States, 06611 | |
| United States, District of Columbia | |
| Washington, District of Columbia, United States, 20010 | |
| United States, Florida | |
| Clearwater, Florida, United States, 33765 | |
| Delray Beach, Florida, United States, 33446 | |
| Jacksonville, Florida, United States, 32216 | |
| Miami, Florida, United States, 33126 | |
| Ponte Verde, Florida, United States, 32081 | |
| United States, Illinois | |
| Bloomingdale, Illinois, United States, 60108 | |
| Chicago, Illinois, United States, 60610 | |
| Chicago, Illinois, United States, 60607 | |
| United States, Indiana | |
| Evansville, Indiana, United States, 47714 | |
| United States, Maryland | |
| Baltimore, Maryland, United States, 21204 | |
| Oxon Hill, Maryland, United States, 20745 | |
| United States, Mississippi | |
| Jackson, Mississippi, United States, 39202 | |
| United States, Missouri | |
| Saint Louis, Missouri, United States, 63141 | |
| United States, Nebraska | |
| North Platte, Nebraska, United States, 69101 | |
| Omaha, Nebraska, United States, 68131 | |
| United States, Nevada | |
| Las Vegas, Nevada, United States, 89104 | |
| Las Vegas, Nevada, United States, 89101 | |
| United States, New Hampshire | |
| Nashua, New Hampshire, United States, 3063 | |
| United States, New Jersey | |
| Toms River, New Jersey, United States, 08753 | |
| United States, New York | |
| Mineola, New York, United States, 11501 | |
| New York, New York, United States, 10032 | |
| United States, North Carolina | |
| Calabash, North Carolina, United States, 28467 | |
| Cary, North Carolina, United States, 27518 | |
| Chapel Hill, North Carolina, United States, 27514 | |
| Charlotte, North Carolina, United States, 28209 | |
| Durham, North Carolina, United States, 27713 | |
| Mooresville, North Carolina, United States, 28117 | |
| Raleigh, North Carolina, United States, 27607 | |
| United States, North Dakota | |
| Bismarck, North Dakota, United States, 58501 | |
| Bismark, North Dakota, United States, 58507 | |
| United States, Ohio | |
| Cleveland, Ohio, United States, 44122 | |
| Kettering, Ohio, United States, 45429 | |
| Toledo, Ohio, United States, 43623 | |
| United States, Oregon | |
| Bend, Oregon, United States, 97701 | |
| Medford, Oregon, United States, 97504 | |
| Portland, Oregon, United States, 97229 | |
| United States, Pennsylvania | |
| Beaver, Pennsylvania, United States, 15009 | |
| Levittown, Pennsylvania, United States, 19056 | |
| Philadelphia, Pennsylvania, United States, 19140 | |
| Pottstown, Pennsylvania, United States, 19464 | |
| United States, South Carolina | |
| Greer, South Carolina, United States, 29651 | |
| Hickory, South Carolina, United States, 28602 | |
| United States, Tennessee | |
| Bristol, Tennessee, United States, 37620 | |
| Johnson City, Tennessee, United States, 37604 | |
| United States, Texas | |
| Austin, Texas, United States, 78705 | |
| Carrollton, Texas, United States, 75010 | |
| Dallas, Texas, United States, 75230 | |
| Dallas, Texas, United States, 75220 | |
| Dallas, Texas, United States, 75246 | |
| Fort Worth, Texas, United States, 76109 | |
| Houston, Texas, United States, 77070 | |
| Irving, Texas, United States, 75039 | |
| North Richland Hills, Texas, United States, 76180 | |
| Richardson, Texas, United States, 75080 | |
| San Antonio, Texas, United States, 78229 | |
| San Antonio, Texas, United States, 78229-4801 | |
| Temple, Texas, United States, 76508 | |
| United States, Utah | |
| Salt Lake City, Utah, United States, 84107 | |
| United States, Virginia | |
| Burke, Virginia, United States, 22015 | |
| Hampton, Virginia, United States, 23666 | |
| Manassas, Virginia, United States, 20110 | |
| Norfolk, Virginia, United States, 23502 | |
| Richmond, Virginia, United States, 23219 | |
| Winchester, Virginia, United States, 22601 | |
| United States, Washington | |
| Tacoma, Washington, United States, 98405 | |
| Australia, Queensland | |
| Freemantle, Queensland, Australia, 6959 | |
| Herston, Queensland, Australia, 4029 | |
| Australia, South Australia | |
| Elizabeth Vale, South Australia, Australia, 5112 | |
| Australia, Victoria | |
| Melbourne, Victoria, Australia, 3004 | |
| Brazil | |
| Fortaleza, CE, Brazil, 60135-170 | |
| Fortaleza, CE, Brazil, 60430-370 | |
| Campina Grande do Sul, PR, Brazil, 83430-000 | |
| Rio de Janeiro, RJ, Brazil, 20211340 | |
| Rio de Janeiro, RJ, Brazil, 22271-100 | |
| Sao Paulo, SP, Brazil, 04266-010 | |
| Sao Paulo, SP, Brazil, 05437-010 | |
| Sao Paulo, SP, Brazil, 04022-001 | |
| Sao Paulo, SP, Brazil, 01244-030 | |
| Sao Paulo, SP, Brazil, 04020-050 | |
| Bulgaria | |
| Byala, Bulgaria, 7100 | |
| Pleven, Bulgaria, 5800 | |
| Plovdiv, Bulgaria, 4002 | |
| Sofia, Bulgaria, 1233 | |
| Sofia, Bulgaria, 1142 | |
| Varna, Bulgaria, 9000 | |
| Canada, Ontario | |
| Barrie, Ontario, Canada, L4M 7G1 | |
| Toronto, Ontario, Canada, M4G 3E8 | |
| Canada, Quebec | |
| Montreal, Quebec, Canada, H2W 1T8 | |
| Sherbrooke, Quebec, Canada, J1G 5K2 | |
| Czech Republic | |
| Havirov, Czech Republic, 76301 | |
| Jindrichuv Hradec, Czech Republic, 377 38 | |
| Marianske Lazne, Czech Republic, 353 01 | |
| Olomouc, Czech Republic, 779 00 | |
| Pardubice, Czech Republic, 530 02 | |
| Praha, Czech Republic, 180 00 | |
| Rakovnik, Czech Republic, 269 01 | |
| Ricany u Prahy, Czech Republic, 250 01 | |
| Semily, Czech Republic, 513 31 | |
| Trutnov, Czech Republic, 541 01 | |
| Uherske Hradiste, Czech Republic, 686 06 | |
| Usti nad Labem, Czech Republic, 400 11 | |
| Denmark | |
| Aalborg, Denmark, 9000 | |
| Ballerup, Denmark, 2750 | |
| Hvidovre, Denmark, 2650 | |
| Vejle, Denmark, 7100 | |
| Estonia | |
| Paide, Estonia, 72714 | |
| Saku, Estonia, 75501 | |
| Tallinn, Estonia, 13415 | |
| Tallinn, Estonia, 11911 | |
| Tallinn, Estonia, 13419 | |
| Tallinn, Estonia, 10128 | |
| Tartu, Estonia, 51010 | |
| Tartu, Estonia, 50410 | |
| Viljandimaa, Estonia, 71024 | |
| Voru, Estonia, 65608 | |
| Germany | |
| Bad Lauterberg, Germany, 37431 | |
| Bad Oeynhausen, Germany, 32545 | |
| Bochum, Germany, 44789 | |
| Dortmund, Germany, 44137 | |
| Dresden, Germany, 01307 | |
| Essen, Germany, 45359 | |
| Hamburg, Germany, 22607 | |
| Kleve, Germany, 47533 | |
| Neuss, Germany, 41460 | |
| Nürnberg, Germany, 90402 | |
| Wuppertal, Germany, 42117 | |
| Hungary | |
| Balatonfuered, Hungary, 8230 | |
| Budapest, Hungary, 1096 | |
| Budapest, Hungary, 1036 | |
| Budapest, Hungary, 1095 | |
| Debrecen, Hungary, 4025 | |
| Gyula, Hungary, 5700 | |
| Hodmezovasarhely, Hungary, 6800 | |
| Komarom, Hungary, 2921 | |
| Mako, Hungary, 6900 | |
| Sopron, Hungary, 9400 | |
| Szikszo, Hungary, 3800 | |
| Urhida, Hungary, 8142 | |
| Veszprem, Hungary, 8200 | |
| India | |
| Ahmedabad, India, 382428 | |
| Aurangabad, India, 431005 | |
| Bangalore, India, 560052 | |
| Bangalore, India, 560003 | |
| Bangalore, India, 560010 | |
| Bangalore, India, 560078 | |
| Banglore, India, 560034 | |
| Bhopal, India, 462003 | |
| Chennai, India, 600086 | |
| Chennai, India, 600006 | |
| Chennai, India, 600013 | |
| Cochin, India, 682026 | |
| Hyderabad, India, 500 033 | |
| Jaipur, India, 302001 | |
| Kolkata, India, 700053 | |
| Madurai, India, 625020 | |
| Mangalore, India, 575001 | |
| Mumbai, India, 400007 | |
| Mumbai, India, 400012 | |
| Nagpur, India, 440010 | |
| Nagpur, India, 440012 | |
| Pune, India, 411 001 | |
| Pune, India, 411004 | |
| Pune, India, 411011 | |
| Israel | |
| Jerusalem, Israel, 91200 | |
| Lithuania | |
| Alytus, Lithuania, 62381 | |
| Kaunas, Lithuania, LT-48426 | |
| Kaunas, Lithuania, 51270 | |
| Kaunas, Lithuania, 49427 | |
| Kaunas, Lithuania, 50009 | |
| Klaipeda, Lithuania, 92304 | |
| Panevezys, Lithuania, 35144 | |
| Vilnius, Lithuania, 08661 | |
| Vilnius, Lithuania, 04318 | |
| Malaysia | |
| Johor, Malaysia, 80100 | |
| Kelantan, Malaysia, 16150 | |
| Penang, Malaysia, 10450 | |
| Mexico | |
| Aguascalientes, Mexico, 20127 | |
| Chihuahua, Mexico, 31238 | |
| Cuernavaca, Mexico, 62250 | |
| Culiacan, Mexico, 80020 | |
| Durango, Mexico, 34000 | |
| Juarez, Distrito Federal, Mexico, 6600 | |
| Mexico, Mexico, 06100 | |
| Mexico City, Mexico, 14000 | |
| Monterrey, Mexico, 64460 | |
| Tampico, Mexico, 89000 | |
| Poland | |
| Gdansk, Poland, 80-858 | |
| Gdynia, Poland, 81-384 | |
| Kamieniec Zabkowicki, Poland, 57-230 | |
| Katowice, Poland, 40-748 | |
| Kielce, Poland, 25-315 | |
| Krakow, Poland, 31-548 | |
| Krakow, Poland, 31-261 | |
| Lodz, Poland, 94-060 | |
| Plock, Poland, 09-402 | |
| Poznan, Poland, 61-655 | |
| Radom, Poland, 26-610 | |
| Warszawa, Poland, 02-692 | |
| Warszawa, Poland, 04-730 | |
| Warszawa, Poland, 01-231 | |
| Wroclaw, Poland, 50-088 | |
| Romania | |
| Bacau, Romania, 600114 | |
| Baia Mare, Romania, 430123 | |
| Bucharest, Romania, 011794 | |
| Bucharest, Romania, 10507 | |
| Bucharest, Romania, 020475 | |
| Bucuresti, Romania, 20475 | |
| Constanta, Romania, 900591 | |
| Galati, Romania, 800371 | |
| Oradea, Romania, 410169 | |
| Ploiesti, Romania, 100342 | |
| Ploiesti, Romania, 100097 | |
| Targu Mures, Romania, 540142 | |
| Timisoara, Romania, 300456 | |
| Russian Federation | |
| Barnaul, Russian Federation, 656055 | |
| Kemerovo, Russian Federation, 650099 | |
| Moscow, Russian Federation, 125299 | |
| Novosibirsk, Russian Federation, 630090 | |
| S. Petersburg, Russian Federation, 194291 | |
| St. Petersburg, Russian Federation, 197706 | |
| St. Petersburg, Russian Federation, 193318 | |
| Slovakia | |
| Banska Bystrica, Slovakia, 975 17 | |
| Bratislava, Slovakia, 813 69 | |
| Bratislava, Slovakia, 82108 | |
| Bratislava, Slovakia, 821 02 | |
| Dolny Kubin, Slovakia, 026 01 | |
| Komarno, Slovakia, 94501 | |
| Levice, Slovakia, 95401 | |
| Levice, Slovakia, 93405 | |
| Lucenec, Slovakia, 98401 | |
| Prievidza, Slovakia, 97101 | |
| Trencin, Slovakia, 911 01 | |
| South Africa | |
| Cape Town, South Africa, 7505 | |
| Cape Town, South Africa, 7130 | |
| Durban, South Africa, 4091 | |
| Johannesburg, South Africa, 1619 | |
| Johannesburg, South Africa, 2113 | |
| Observatory, Cape Town, South Africa, 7925 | |
| Port Elizabeth, South Africa, 6014 | |
| Pretoria, South Africa, 0112 | |
| Pretoria, South Africa, 0184 | |
| Richards Bay, South Africa, 3900 | |
| Soweto, South Africa, 1818 | |
| Soweto, South Africa, 2013 | |
| Spain | |
| Lugo, Spain, 27004 | |
| Madrid, Spain, 28040 | |
| Taiwan | |
| Taichung, Taiwan, 404 | |
| Taipei, Taiwan, 114 | |
| Taipei, Taiwan, 106 | |
| Taipei, Taiwan, 111 | |
| Taipei, Taiwan, 112 | |
| Taoyuan County, Taiwan, 333 | |
| Thailand | |
| Bangkok, Thailand, 10400 | |
| Bangkok, Thailand, 10330 | |
| Chiang Mai, Thailand, 50200 | |
| Ukraine | |
| Kharkiv, Ukraine, 61022 | |
| Kiev, Ukraine, 1004 | |
| Kiev, Ukraine, 02175 | |
| Lviv, Ukraine, 79010 | |
| Mykolaiv, Ukraine, 54003 | |
| Poltava, Ukraine, 36024 | |
| Ternopil, Ukraine, 46002 | |
| Vinnitsa, Ukraine, 21010 | |
| Zaporizhzhya, Ukraine, 69035 | |
| Zaporizhzhya, Ukraine, 69001 | |
| United Kingdom | |
| Bexhill on Sea, United Kingdom, TN39 4SP | |
| Birmingham, United Kingdom, B15 2SQ | |
| Cardiff, United Kingdom, CF14 5GJ | |
| Chorley, United Kingdom, PR7 7NA | |
| Dundee, United Kingdom, DD1 9SY | |
| Glasgow, United Kingdom, G20 0SP | |
| Liverpool, United Kingdom, L7 8XP | |
| Liverpool, United Kingdom, L22 0LG | |
| London, United Kingdom, E1 2ES | |
| Manchester, United Kingdom, M15 6SX | |
| Reading, United Kingdom, RG2 7AG | |
| Salford, United Kingdom, M6 8HD | |
Sponsors and Collaborators
Hoffmann-La Roche
Investigators
| Study Director: | Clinical Trials | Hoffmann-La Roche |
More Information
No publications provided
| Responsible Party: | Hoffmann-La Roche |
| ClinicalTrials.gov Identifier: | NCT01018173 History of Changes |
| Other Study ID Numbers: | NC25113, 2009-014986-22 |
| Study First Received: | November 20, 2009 |
| Last Updated: | March 2, 2015 |
| Health Authority: | United States: Food and Drug Administration |
Additional relevant MeSH terms:
|
Cardiovascular Diseases Diabetes Mellitus Diabetes Mellitus, Type 2 |
Endocrine System Diseases Glucose Metabolism Disorders Metabolic Diseases |
ClinicalTrials.gov processed this record on March 02, 2015